Veracyte (VCYT) News Today $31.87 +0.99 (+3.21%) Closing price 09/15/2025 04:00 PM EasternExtended Trading$31.80 -0.07 (-0.23%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock VCYT Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period AQR Capital Management LLC Lowers Stock Position in Veracyte, Inc. $VCYTSeptember 15 at 3:12 AM | marketbeat.comVeracyte, Inc. $VCYT Stake Trimmed by Great Lakes Advisors LLCSeptember 13 at 4:19 AM | marketbeat.comVeracyte (NASDAQ:VCYT) CEO Sells 7,667 SharesSeptember 10, 2025 | marketbeat.comVeracyte Announces That More Than 10 Afirma-Focused Studies Will Be Presented at the 2025 American Thyroid Association Annual MeetingSeptember 10, 2025 | finance.yahoo.comVeracyte, Inc. (VCYT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 9, 2025 | seekingalpha.comMarc Stapley Sells 7,667 Shares of Veracyte (NASDAQ:VCYT) StockSeptember 9, 2025 | insidertrades.comVeracyte, Inc. (NASDAQ:VCYT) Receives $40.90 Average Target Price from AnalystsSeptember 9, 2025 | americanbankingnews.comVeracyte, Inc. $VCYT Stake Lifted by Parkman Healthcare Partners LLCSeptember 8, 2025 | marketbeat.comBridgeway Capital Management LLC Sells 41,300 Shares of Veracyte, Inc. $VCYTSeptember 8, 2025 | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Receives Average Recommendation of "Moderate Buy" from AnalystsSeptember 8, 2025 | marketbeat.comRaymond James Financial Inc. Purchases 172,010 Shares of Veracyte, Inc. $VCYTSeptember 6, 2025 | marketbeat.comPDT Partners LLC Sells 27,566 Shares of Veracyte, Inc. $VCYTSeptember 5, 2025 | marketbeat.comMagnetar Financial LLC Invests $651,000 in Veracyte, Inc. $VCYTSeptember 3, 2025 | marketbeat.comTrexquant Investment LP Sells 10,790 Shares of Veracyte, Inc. $VCYTSeptember 3, 2025 | marketbeat.comHsbc Holdings PLC Buys 10,618 Shares of Veracyte, Inc. $VCYTSeptember 2, 2025 | marketbeat.comRafferty Asset Management LLC Has $3.29 Million Stock Position in Veracyte, Inc. $VCYTSeptember 1, 2025 | marketbeat.comNorthern Trust Corp Trims Stake in Veracyte, Inc. $VCYTSeptember 1, 2025 | marketbeat.comDriehaus Capital Management LLC Purchases 167,604 Shares of Veracyte, Inc. $VCYTAugust 31, 2025 | marketbeat.comRussell Investments Group Ltd. Sells 28,644 Shares of Veracyte, Inc. $VCYTAugust 31, 2025 | marketbeat.comNext Century Growth Investors LLC Lowers Stake in Veracyte, Inc. $VCYTAugust 30, 2025 | marketbeat.comVeracyte to Participate in the Morgan Stanley 23rd Annual Global Healthcare ConferenceAugust 29, 2025 | businesswire.comVeracyte reports Phase 3 STAMPEDE trial finding published in CellAugust 28, 2025 | msn.comVeracyte Announces New Study Published in Cell Shows that Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate CancerAugust 27, 2025 | businesswire.comVirtus Advisers LLC Acquires Shares of 36,230 Veracyte, Inc. $VCYTAugust 27, 2025 | marketbeat.com76,342 Shares in Veracyte, Inc. $VCYT Acquired by Campbell & CO Investment Adviser LLCAugust 27, 2025 | marketbeat.comInvesco Ltd. Lowers Position in Veracyte, Inc. $VCYTAugust 27, 2025 | marketbeat.comVeracyte Completes NIGHTINGALE Clinical Utility Trial Enrollment for Percepta Nasal Swab Lung Cancer TestAugust 26, 2025 | finance.yahoo.comVeracyte: Q2 Earnings Brings My Position Out Of MothballsAugust 26, 2025 | seekingalpha.comHow Investors May Respond To Veracyte (VCYT) Earnings Upgrades and Spotlight as a Momentum StockAugust 24, 2025 | finance.yahoo.comAdvantage Alpha Capital Partners LP Has $779,000 Stake in Veracyte, Inc. $VCYTAugust 24, 2025 | marketbeat.comWellington Management Group LLP Has $114.25 Million Stake in Veracyte, Inc. $VCYTAugust 24, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Has $21.96 Million Stake in Veracyte, Inc. $VCYTAugust 24, 2025 | marketbeat.comCraig-Hallum Sticks to Its Buy Rating for Veracyte (VCYT)August 23, 2025 | theglobeandmail.comCraig-Hallum Remains a Buy on Veracyte (VCYT)August 23, 2025 | theglobeandmail.comDeutsche Bank AG Sells 9,272 Shares of Veracyte, Inc. $VCYTAugust 23, 2025 | marketbeat.com15,400 Shares in Veracyte, Inc. $VCYT Acquired by Northwest & Ethical Investments L.P.August 22, 2025 | marketbeat.comEverSource Wealth Advisors LLC Acquires 15,832 Shares of Veracyte, Inc. $VCYTAugust 20, 2025 | marketbeat.comVanguard Group Inc. Increases Holdings in Veracyte, Inc. $VCYTAugust 20, 2025 | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Shares Sold by Lord Abbett & CO. LLCAugust 19, 2025 | marketbeat.comNuveen LLC Purchases New Position in Veracyte, Inc. (NASDAQ:VCYT)August 19, 2025 | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Shares Sold by Vestmark Advisory Solutions Inc.August 18, 2025 | marketbeat.comWellington Management Group LLP Reduces Stake in Veracyte IncAugust 17, 2025 | gurufocus.comArtisan Partners Limited Partnership Expands Stake in Veracyte IncAugust 17, 2025 | gurufocus.comShareholders Can Be Confident That Veracyte's (NASDAQ:VCYT) Earnings Are High QualityAugust 16, 2025 | uk.finance.yahoo.comConnor Clark & Lunn Investment Management Ltd. Decreases Holdings in Veracyte, Inc. (NASDAQ:VCYT)August 13, 2025 | marketbeat.comVeracyte (NASDAQ:VCYT) Stock Price Up 12.5% - Should You Buy?August 8, 2025 | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | msn.comDecoding Veracyte Inc (VCYT): A Strategic SWOT InsightAugust 7, 2025 | gurufocus.comVeracyte, Inc. (VCYT) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | seekingalpha.comVeracyte, Inc. 2025 Q2 - Results - Earnings Call PresentationAugust 7, 2025 | seekingalpha.com Get Veracyte News Delivered to You Automatically Sign up to receive the latest news and ratings for VCYT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. VCYT Media Mentions By Week VCYT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VCYT News Sentiment▼1.160.92▲Average Medical News Sentiment VCYT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VCYT Articles This Week▼78▲VCYT Articles Average Week Get the Latest News and Ratings for VCYT and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Veracyte and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Adaptive Biotechnologies News Today Beam Therapeutics News Today Guardant Health News Today Twist Bioscience News Today 10x Genomics News Today RadNet News Today Option Care Health News Today Sotera Health News Today BrightSpring Health Services News Today GeneDx News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VCYT) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredIf you own dollars, read this...Former Goldman Exec: "A Strange Day Is Coming to America" Dr. David Eifrig, who warned of inflation months ...Stansberry Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veracyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veracyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
